☆ 4.7 Letter

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

DIABETOLOGIA (2009)

Get Full Text
Add to Collection

Journal

DIABETOLOGIA
Volume 52, Issue 9, Pages 1971-1973

Publisher

SPRINGER
DOI: 10.1007/s00125-009-1452-2

Keywords

Cancer; Insulin analogues; Insulin glargine; Insulin therapy; Malignancy; NPH insulin; Type 2 diabetes

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.